Table 2.
Influenza season | Doses (×10,000) | ||||
---|---|---|---|---|---|
NA inhibitors | Polymerase inhibitor | ||||
Zanamivir | Oseltamivir | Peramivir | Laninamivir | Baloxavir | |
2009–2010 | 515 | 859 | 0.5 | – | – |
2010–2011 | 54 | 240 | 13 | 166 | – |
2011–2012 | 127 | 356 | 26 | 270 | – |
2012–2013 | 110 | 358 | 35 | 280 | – |
2013–2014 | 151 | 336 | 37 | 330 | – |
2014–2015 | 132 | 422 | 37 | 400 | – |
2015–2016 | 40 | 375 | 40 | 368 | – |
2016–2017 | 151 | 453 | 50 | 485 | – |
2017–2018 | 158 | 570 | 60 | 690 | 40 |
2018–2019 | 59 | 464 | 32 | 289 | 528 |
Data adapted from notification on stable supply of influenza antivirals from the Ministry of Health, Labour, and Welfare, Japan.
(NA) Neuraminidase, (–) unapproved.